Recent Company News

• 07:36 AM ET Jan 21, 2026
  

  BrainsWay announces draft coverage policy from Highmark for accelerated deep TMS ($22.13, 0.00)

• 09:21 AM ET Jan 12, 2026
  

  StreetAccount Summary - US Pre-market trading update

• 08:25 AM ET Jan 12, 2026
  

  StreetAccount Summary - US Pre-market trading

• 07:35 AM ET Jan 12, 2026
  

  BrainsWay announces FDA approval of neurolief's ProlivRx Neuromodulation system for major depressive disorder (MDD) ($23.11, 0.00)

• 10:02 AM ET Jan 07, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (140 total)

• 10:03 AM ET Jan 05, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (206 total)

• 09:53 AM ET Dec 24, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (94 total)

• 10:02 AM ET Dec 23, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (170 total)

• 07:32 AM ET Dec 22, 2025
  

  Brainsway announces Optum Behavioral Health expands medical policy applicable to Deep TMS ($17.11, 0.00)

• 10:02 AM ET Dec 10, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (126 total)